Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For:	[Subscribe] [Scholar Register]

Number	Cited by Other Article(s)
1	Mann EL. Subsidised access to TNF-alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible? Med J Aust 2005;182:47-8. [PMID: 15651955 DOI: 10.5694/j.1326-5377.2005.tb06566.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2004] [Accepted: 10/15/2004] [Indexed: 11/17/2022] Abstract Collapse Key Words Collapse MESH Headings Arthritis, Rheumatoid/drug therapy Arthritis, Rheumatoid/immunology Australia Health Care Rationing/methods Humans Neoplasm Proteins/economics Neoplasm Proteins/therapeutic use Patient Selection Receptors, Tumor Necrosis Factor, Type II Rheumatoid Factor/blood Treatment Outcome Tumor Necrosis Factor Decoy Receptors Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Mann EL. Subsidised access to TNF-alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible? Med J Aust 2005;182:47-8. [PMID: 15651955 DOI: 10.5694/j.1326-5377.2005.tb06566.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2004] [Accepted: 10/15/2004] [Indexed: 11/17/2022]